Ultime prove

EudraCT Number: 2005-000808-14

Sponsor Protocol Number: AD-CT-01/05

Start Date: 2005-05-24

Sponsor Name: Ambria Dermatology

Full Title: A randomized, double-blind, parallell-group, controlled study of topical pentane-1,5-diol hydrogel in patients with impetigo

Medical condition: Impetigo

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Children, Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: SE (Completed)

Trial results: (No results available)

EudraCT Number: 2004-005282-37

Sponsor Protocol Number: IDT.LM.LEV.22004-LEMDE

Start Date: 2005-05-24

Sponsor Name: QUIMICA FARMACEUTICA BAYER, S.A.

Full Title: Double-blind, cross-over, placebo-controlled pilot study to characterize the profile of those patients with traumatic spinal cord injury diagnosed by electrophysiological, urodynamic and clinical (...

Medical condition: Erectile dysfunction (ED)

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults

Gender: Male

Trial protocol: ES (Completed)

Trial results: View results

EudraCT Number: 2004-005184-15

Sponsor Protocol Number: 05_ENDO_46

Start Date: 2005-05-24

Sponsor Name: Christie Hospital NHS Trust

Full Title: Central Hypothyroidism and Adjusted Thyroxine dose Study (CHATS): impact of increasing free thyroxine levels in patients with hypopituitarism

Medical condition: Central (secondary/tertiary) hypothyroidism (subclinical)

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: View results

EudraCT Number: 2005-000380-26

Sponsor Protocol Number: CERTES02 (Ce-PoP-RAD001A2419)

Start Date: 2005-05-24

Sponsor Name: Novartis Farmacéutica S.A.

Full Title: A 12 month, multicenter, randomized, parallel, open-label study, to evaluate renal function and efficacy of Certican® (everolimus) with Simulect® (basiliximab) and cyclosporine discontinuation at 3...

Medical condition: Renal Transplant

Disease:	Version	SOC Term	Classification Code	Term	Level
	M15		10023438

Population Age: Adults

Gender: Male, Female

Trial protocol: ES (Completed)

Trial results: View results

EudraCT Number: 2005-000807-33

Sponsor Protocol Number: EFC5823

Start Date: 2005-05-24

Sponsor Name: sanofi-aventis recherche & développement

Full Title: Randomized, double-blind, two -arms placebo-controlled, parallel-group, multicenter study of rimonabant 20 mg once daily in the treatment of atherogenic dyslipidemia in abdominally obese patients.

Medical condition: Abdominally obese patients with atherogenic dyslipidemia

Disease:	Version	SOC Term	Classification Code	Term	Level
	7.1		10058110		LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: SE (Completed) DK (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2005-001378-29

Sponsor Protocol Number: RAE02

Start Date: 2005-05-23

Sponsor Name: Bradford Teaching Hospitals NHS Foundation Trust

Full Title: A double blinded randomised controlled trial of injection of botulinum toxin versus normal saline into the puborectalis muscle in patients with pelvic floor dyssynergia.

Medical condition: Obstructed defeacation

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: (No results available)

EudraCT Number: 2004-004670-88

Sponsor Protocol Number: 4975-2-007-2

Start Date: 2005-05-23

Sponsor Name: AlgoRx Pharmaceuticals, Inc.

Full Title: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Analgesic Efficacy, Safety and Tolerability of ALGRX 4975 in Subjects after Inguinal Hernia Repair

Medical condition: Inguinal Hernia

Disease:	Version	SOC Term	Classification Code	Term	Level
	7.1		10022020		LLT

Population Age: Adults, Elderly

Gender: Male

Trial protocol: DK (Ongoing)

Trial results: (No results available)

EudraCT Number: 2005-000867-24

Sponsor Protocol Number: ALFR-HC-04

Start Date: 2005-05-23

Sponsor Name: Human Genome Sciences, Inc.

Full Title: A PHASE 2b, RANDOMIZED, MULTI-CENTER, ACTIVE-CONTROLLED, OPEN-LABEL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALBUFERON (RECOMBINANT HUMAN ALBUMIN-INTERFERON ALFA FUSION PROTEIN) IN COMBINATION...

Medical condition: Hepatitis type C chronic

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults

Gender: Male, Female

Trial protocol: DE (Completed) CZ (Completed)

Trial results: View results

EudraCT Number: 2004-002676-41

Sponsor Protocol Number: 100388,103494,104105,104106

Start Date: 2005-05-23

Sponsor Name: GlaxoSmithKline Biologicals

Full Title: Blinded, randomised, controlled, multicenter study to evaluate the clinical efficacy against varicella disease of GlaxoSmithKline Biologicals’ live attenuated varicella vaccine (Varilrix) given on ...

Medical condition: Healthy children between 12-22 months (including the day before the 23-month birthday) of age at the time of vaccination with no history of measles, mumps, rubella and varicella diseases/vaccination.

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.1	10021881 - Infections and infestations	10028257	Mumps	PT
	14.1	10021881 - Infections and infestations	10046980	Varicella	PT
	14.1	10021881 - Infections and infestations	10039252	Rubella	PT
	14.1	10021881 - Infections and infestations	10027011	Measles	PT

Population Age: Infants and toddlers, Under 18

Gender: Male, Female

Trial protocol: SE (Completed) LT (Completed) SK (Completed) CZ (Completed) IT (Completed)

Trial results: (No results available)

EudraCT Number: 2005-001774-27

Sponsor Protocol Number: AISSM03

Start Date: 2005-05-23

Sponsor Name: AISSM ONLUS

Full Title: CAMPATH-1H AS IMMUNOSUPPRESSIVE AGENT IN MDS PATIENTS MULTICENTRIC PILOT STUDY

Medical condition: In this study we want to assess the potential of CAMPATH-1H as an immunosuppressive agent in a series of selected MDS patients, because T lymphocytes are thought to play an important role in the ...

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10028536		HLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Prematurely Ended)

Trial results: (No results available)

Ultime prove

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici